Form 4: CoreWeave CDO Sells $9M+ in Stock via Pre-Planned Trades

CoreWeave's Chief Development Officer, Brannin McBee, executed pre-planned sales of over 105,000 Class A Common Stock shares totaling approximately $9 million on January 12, 2026.

Summary

• Brannin McBee, Chief Development Officer of CoreWeave, Inc., reported transactions on January 12, 2026, involving both direct and indirect holdings.
• Directly, 102,835 shares of Class B Common Stock were converted into Class A Common Stock.
• Concurrently, 102,835 shares of Class A Common Stock were sold directly at weighted average prices ranging from $78.5355 to $91.7379.
• Indirectly, through the Canis Major 2024 Irrevocable Trust LLC (managed by Mr. McBee), 3,000 shares of Class B Common Stock were converted to Class A Common Stock.
• The Trust then sold these 3,000 Class A Common Stock shares at weighted average prices ranging from $78.8273 to $91.87.
• All reported sales were conducted pursuant to a Rule 10b5-1 trading plan adopted on September 2, 2025.
• Following these transactions, Mr. McBee directly holds 248,664 Class A Common Stock and 8,705,815 Class B Common Stock.
• The Canis Major 2024 Irrevocable Trust LLC holds 0 Class A Common Stock and 339,000 Class B Common Stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While insider selling can sometimes be viewed negatively, the fact that these sales were executed under a pre-arranged 10b5-1 plan mitigates concerns about a sudden loss of confidence by the insider. It represents a planned liquidity event.

Positives

• The sales were executed under a pre-arranged Rule 10b5-1 trading plan, indicating a structured approach to liquidity and diversification rather than an immediate reaction to new, undisclosed information.

Negatives

• A significant sale of over 105,000 shares by a Chief Development Officer could be perceived as a reduction in insider confidence, although this is mitigated by the pre-planned nature of the transactions.

Future Outlook

NA

Industry Context

This filing reflects routine insider transaction reporting for a publicly traded company. The execution of sales under a 10b5-1 plan is a common practice among executives to manage personal liquidity and diversify holdings in a compliant manner, without necessarily signaling a change in company-specific outlook.

Related Party Transactions

• Sales of Class A Common Stock were conducted indirectly through the Canis Major 2024 Irrevocable Trust LLC, which the reporting person, Brannin McBee, serves as manager.

Stakeholder Impact

• Shareholders may observe a reduction in direct and indirect insider holdings, which could be interpreted as a slight decrease in insider alignment, though the 10b5-1 plan context suggests a planned diversification.

Key Dates

Recommendation

The filing details pre-planned insider sales by a Chief Development Officer under a Rule 10b5-1 plan. While a significant volume of shares were sold, the pre-scheduled nature of these transactions typically reduces the negative signal often associated with insider selling. It suggests a planned liquidity event or portfolio diversification rather than a reaction to adverse company-specific news. Without additional company-specific or market information, these transactions alone do not warrant a change from a 'hold' position.

Keywords

CoreWeave, CRWV, Insider Trading, Form 4, Stock Sale, Brannin McBee, Chief Development Officer, 10b5-1 Plan, Equity Transaction, Class A Common Stock, Class B Common Stock